BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20196486)

  • 1. [The discovery of an antiparkinsonian drug, zonisamide].
    Murata M
    Rinsho Shinkeigaku; 2010 Feb; 50(2):67-73. PubMed ID: 20196486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Discovery of an antiparkinsonian drug: zonisamide].
    Murata M
    Rinsho Shinkeigaku; 2010 Nov; 50(11):780-2. PubMed ID: 21921440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease.
    Murata M
    Curr Pharm Des; 2004; 10(6):687-93. PubMed ID: 14965331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide: a new drug for Parkinson's disease.
    Murata M
    Drugs Today (Barc); 2010 Apr; 46(4):251-8. PubMed ID: 20502722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zonisamide has beneficial effects on Parkinson's disease patients.
    Murata M; Horiuchi E; Kanazawa I
    Neurosci Res; 2001 Dec; 41(4):397-9. PubMed ID: 11755227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases].
    Janszky J
    Ideggyogy Sz; 2009 Nov; 62(11-12):383-9. PubMed ID: 20025128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of Parkinson's disease--up to date].
    Murata M
    Rinsho Shinkeigaku; 2008 Nov; 48(11):986-8. PubMed ID: 19198140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of zonisamide on resting tremor resistant to antiparkinsonian medication].
    Nakanishi I; Kohmoto J; Miwa H; Kondo T
    No To Shinkei; 2003 Aug; 55(8):685-9. PubMed ID: 13677302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Miyoshi K; Ogawa N; Murata M
    Neurosci Res; 2008 Jan; 60(1):106-13. PubMed ID: 18022268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of zonisamide on dopaminergic system.
    Okada M; Kaneko S; Hirano T; Mizuno K; Kondo T; Otani K; Fukushima Y
    Epilepsy Res; 1995 Nov; 22(3):193-205. PubMed ID: 8991786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zonisamide inhibits monoamine oxidase and enhances motor performance and social activity.
    Uemura MT; Asano T; Hikawa R; Yamakado H; Takahashi R
    Neurosci Res; 2017 Nov; 124():25-32. PubMed ID: 28624436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide enhances delta receptor-associated neurotransmitter release in striato-pallidal pathway.
    Yamamura S; Ohoyama K; Nagase H; Okada M
    Neuropharmacology; 2009 Sep; 57(3):322-31. PubMed ID: 19482038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's disease.
    Grover ND; Limaye RP; Gokhale DV; Patil TR
    Indian J Pharmacol; 2013; 45(6):547-55. PubMed ID: 24347760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of zonisamide target astrocyte.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Kimoto N; Kikkawa Y; Takeshima M; Miyoshi K; Murata M
    Ann Neurol; 2010 Feb; 67(2):239-49. PubMed ID: 20225289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study.
    Ikeda K; Yanagihashi M; Miura K; Ishikawa Y; Hirayama T; Takazawa T; Kano O; Kawabe K; Mizumura N; Iwasaki Y
    J Neurol Sci; 2018 Aug; 391():5-9. PubMed ID: 30103971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide in West syndrome.
    Suzuki Y
    Brain Dev; 2001 Nov; 23(7):658-61. PubMed ID: 11701273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental and therapeutic pharmacology of antiepileptic drugs.
    Miura H
    Epilepsia; 2000; 41 Suppl 9():2-6. PubMed ID: 11156504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional accumulation of 14C-zonisamide in rat brain during kainic acid-induced limbic seizures.
    Akaike K; Tanaka S; Tojo H; Fukumoto S; Imamura S; Takigawa M
    Can J Neurol Sci; 2001 Nov; 28(4):341-5. PubMed ID: 11766778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors.
    Yoshida S; Okada M; Zhu G; Kaneko S
    Epilepsy Res; 2005 Dec; 67(3):153-62. PubMed ID: 16289509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide: a new antiepileptic drug.
    Sobieszek G; Borowicz KK; Kimber-Trojnar Z; Małek R; Piskorska B; Czuczwar SJ
    Pol J Pharmacol; 2003; 55(5):683-9. PubMed ID: 14704463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.